Citation:
Liu W, Zi M, Tsui H, Chowdhury SK, Zeef L, Meng Q-J, Travis M, Prehar S, Berry A, Hanley NA, et al. A novel immunomodulator, FTY-720 reverses existing cardiac hypertrophy and fibrosis from pressure overload by targeting NFAT (nuclear factor of activated T-cells) signaling and periostin. Circulation: Heart Failure [Internet]. 2013;(4):833-844.